archive-fr.com » FR » I » IT-INITIATIVE.FR

Total: 133

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • Investment Strategy
    of Inserm Transfert Initiative InotremRaises 18 million to Develop Innovative Sepsis Treatmentsin a Series A Financing Co led by Edmon de Rothschild Investment Partners and Sofinnova Partners Axilum Robotics announces Health Canada licence for TMS Robot the world s first robot developed specifically for Transcranial Magnetic Stimulation TMS We syndicate with financial partners who share our strategy teaming up with scientific founders to foster innovation and entrepreneurship Prior to investing

    Original URL path: http://www.it-initiative.fr/investment/our-seed-investment-strategy?style=red (2015-10-11)
    Open archived version from archive


  • Investment Strategy
    of Inserm Transfert Initiative InotremRaises 18 million to Develop Innovative Sepsis Treatmentsin a Series A Financing Co led by Edmon de Rothschild Investment Partners and Sofinnova Partners Axilum Robotics announces Health Canada licence for TMS Robot the world s first robot developed specifically for Transcranial Magnetic Stimulation TMS We syndicate with financial partners who share our strategy teaming up with scientific founders to foster innovation and entrepreneurship Prior to investing

    Original URL path: http://www.it-initiative.fr/investment/our-seed-investment-strategy?style=orange (2015-10-11)
    Open archived version from archive

  • Investment Strategy
    of Inserm Transfert Initiative InotremRaises 18 million to Develop Innovative Sepsis Treatmentsin a Series A Financing Co led by Edmon de Rothschild Investment Partners and Sofinnova Partners Axilum Robotics announces Health Canada licence for TMS Robot the world s first robot developed specifically for Transcranial Magnetic Stimulation TMS We syndicate with financial partners who share our strategy teaming up with scientific founders to foster innovation and entrepreneurship Prior to investing

    Original URL path: http://www.it-initiative.fr/investment/our-seed-investment-strategy?style=blue (2015-10-11)
    Open archived version from archive

  • Investment Process
    of Inserm Transfert Initiative InotremRaises 18 million to Develop Innovative Sepsis Treatmentsin a Series A Financing Co led by Edmon de Rothschild Investment Partners and Sofinnova Partners Axilum Robotics announces Health Canada licence for TMS Robot the world s first robot developed specifically for Transcranial Magnetic Stimulation TMS Due diligence processes are partnered with a network of key opinion leaders and entrepreneurs from academic research industry and venture capital Our

    Original URL path: http://www.it-initiative.fr/investment/investment-process?style=green (2015-10-11)
    Open archived version from archive

  • Investment Process
    of Inserm Transfert Initiative InotremRaises 18 million to Develop Innovative Sepsis Treatmentsin a Series A Financing Co led by Edmon de Rothschild Investment Partners and Sofinnova Partners Axilum Robotics announces Health Canada licence for TMS Robot the world s first robot developed specifically for Transcranial Magnetic Stimulation TMS Due diligence processes are partnered with a network of key opinion leaders and entrepreneurs from academic research industry and venture capital Our

    Original URL path: http://www.it-initiative.fr/investment/investment-process?style=red (2015-10-11)
    Open archived version from archive

  • Investment Process
    of Inserm Transfert Initiative InotremRaises 18 million to Develop Innovative Sepsis Treatmentsin a Series A Financing Co led by Edmon de Rothschild Investment Partners and Sofinnova Partners Axilum Robotics announces Health Canada licence for TMS Robot the world s first robot developed specifically for Transcranial Magnetic Stimulation TMS Due diligence processes are partnered with a network of key opinion leaders and entrepreneurs from academic research industry and venture capital Our

    Original URL path: http://www.it-initiative.fr/investment/investment-process?style=orange (2015-10-11)
    Open archived version from archive

  • Investment Process
    of Inserm Transfert Initiative InotremRaises 18 million to Develop Innovative Sepsis Treatmentsin a Series A Financing Co led by Edmon de Rothschild Investment Partners and Sofinnova Partners Axilum Robotics announces Health Canada licence for TMS Robot the world s first robot developed specifically for Transcranial Magnetic Stimulation TMS Due diligence processes are partnered with a network of key opinion leaders and entrepreneurs from academic research industry and venture capital Our

    Original URL path: http://www.it-initiative.fr/investment/investment-process?style=blue (2015-10-11)
    Open archived version from archive

  • Portfolio
    resolution imaging instruments for the worldwide R D teams of the Life Sciences and Healthcare Bioaxial breakthrough technology enables enhanced imaging capabilities required for advanced research Bioaxial offers a range of improved imaging solutions integrated to confocal microscopes platforms This flexible offering enables the user to easily upgrade existing confocal microscopes for improved resolution website DNA Therapeutics Novel approach using DNA fragments siDNA mimicking DNA damage By jamming DNA damage sensing and signaling siDNA can increase the efficacy of radiotherapy and chemotherapy without adding any cytotoxic effect The lead compound DT01 is currently in phase I IIa in melanoma website Effimune Discovery and the development of novel immunomodulators and more specifically modulatory drugs for the co stimulation of T cells The lead antibody FR104 is a CD28 antagonist under regulatory preclinical development showing promising proof of concept in the protection of graft rejections website Eyevensys Novel solutions for sustainable intraocular production of therapeutic proteins website Genoscreen Services related to detection and characterization of genetic variants sequencing and genotyping SNPs microsatellites website Hemarina Development of a haemoglobin oxygen carrier extracted and purified from a marine organism Hemarina positions itself as an R D company focused on oxygen carrier molecules that have therapeutic and industrial applications The lead compound HEMO2Life will enter clinical development based on promising proof of concept results as an additive to organ preservation solutions website Mutabilis Novel generation of anti retroviral molecules Instead of targeting the inhibition of the catalytic activity of viral enzymes the lead compound targets host virus protein protein interactions ex cellvir website Neorphys Novel analgesic drug candidates with lower side effects especially with regard to gastro intestinal transit The lead compound NEO1509 is under regulatory preclinical development The first indication will be postoperative pain website Neurokin Novel generation of CDK inhibitors as neuroprotectants for

    Original URL path: http://www.it-initiative.fr/portfolio?style=green (2015-10-11)
    Open archived version from archive